Showing 39,241 - 39,260 results of 110,994 for search '(( a point decrease ) OR ( 5 ((mean decrease) OR (((we decrease) OR (a decrease)))) ))', query time: 1.95s Refine Results
  1. 39241
  2. 39242

    The A<sub>1</sub> chain of SLT-1 harbors a cationic surface composed of a cluster of arginine residues that interact with the ribosomal stalk protein P2 and the conserved C-termina... by Andrew J. McCluskey (183382)

    Published 2012
    “…<p>(A) A vector expressing a catalytically inactive variant of the SLT-1 A<sub>1</sub> domain (CIA<sub>1</sub>) or one of the arginine-to-alanine point mutants as fusion partners with the GAL4 DNA-BD domain were co-transformed in the yeast strain AH109 with a vector expressing ribosomal protein P2 as a fusion construct to the GAL4-AD. …”
  3. 39243

    ROCK inhibitor Y-27632 on the morphology and growth of porcine trophoblast cells. by Dongxia Hou (566461)

    Published 2015
    “…E) The mean colony area curve of pPATR-5 shows similar trend with the cell number curve. …”
  4. 39244

    Recordings of somatosensory-evoked potential (SSEP) amplitudes. by Feng Qiu (496465)

    Published 2015
    “…The amplitude of the first positive wave was 0.1 uV and the peak latency was 38 ms. The amplitude decreased by 52.4% and the peak latency was delayed by 12% after spinal cord shortening compared with the normal conditions. ch, channel; P, positive; A, amplitude.…”
  5. 39245

    Sdc-1 deficiency does not affect TLR2 or TR9 triggered DC maturation or function. by M. Kouwenberg (2950749)

    Published 2020
    “…Experiments were replicated 3–5 times. Results are expresses as mean ± standard error of means. * p< 0.05 (Mann Whitney test).…”
  6. 39246
  7. 39247

    DataSheet1_Scoparone Improves Nonalcoholic Steatohepatitis Through Alleviating JNK/Sab Signaling Pathway-Mediated Mitochondrial Dysfunction.docx by Yuwei Jiang (451886)

    Published 2022
    “…Whether mitochondrial dysfunction induced by the JNK/Sab signaling pathway plays a pivotal role in the lipotoxic injury of nonalcoholic steatohepatitis (NASH) remains a lack of evidence. …”
  8. 39248

    Response to a constant input current. by Inés Samengo (251860)

    Published 2010
    “…The two singular points correspond to the onset of firing at nA, and the change in the size of bursts from 3 spike bursts to 4 spike bursts at nA. …”
  9. 39249
  10. 39250
  11. 39251
  12. 39252

    Synthesis and Characterization of a New Family of Mixed Oxide−Proton Conductors Based on Tristrontium Oxysilicate by José M. Porras-Vázquez (2450377)

    Published 2008
    “…This compound crystallizes in the <i>P</i>4/<i>ncc</i> space group, <i>Z</i> = 4, with <i>a</i> = 6.9427(1) Å, <i>c</i> = 10.7992(1) Å, and <i>V</i> = 520.53(1) Å<sup>3</sup>. …”
  13. 39253

    Synthesis and Characterization of a New Family of Mixed Oxide−Proton Conductors Based on Tristrontium Oxysilicate by José M. Porras-Vázquez (2450377)

    Published 2008
    “…This compound crystallizes in the <i>P</i>4/<i>ncc</i> space group, <i>Z</i> = 4, with <i>a</i> = 6.9427(1) Å, <i>c</i> = 10.7992(1) Å, and <i>V</i> = 520.53(1) Å<sup>3</sup>. …”
  14. 39254
  15. 39255
  16. 39256
  17. 39257

    Table_5_Global Transcriptomic Analysis of the Canine corpus luteum (CL) During the First Half of Diestrus and Changes Induced by in vivo Inhibition of Prostaglandin Synthase 2 (PTG... by Miguel Tavares Pereira (7857989)

    Published 2019
    “…Samples from a previous in vivo study were used; bitches were treated for 5, 10, 20, or 30 days after ovulation with firocoxib (Previcox®), a PTGS2/COX2 inhibitor, or a placebo. …”
  18. 39258

    Image 5_MIF tautomerase inhibitor TE-11 prevents inflammatory macrophage activation and glycolytic reprogramming while reducing leukocyte migration and improving Crohn’s disease-li... by Eszter Vámos (11081587)

    Published 2025
    “…Leukocyte recruitment, M1 macrophage polarization and associated metabolic reprogramming are hallmarks of its pathomechanism. Here, we tested TE-11, a potent MIF tautomerase inhibitor (IC<sub>50</sub> = 5.63 μmol/dm<sup>3</sup>) in experimental Crohn’s disease in male mice, in leukocyte recruitment and in inflammatory M1 macrophage activation.…”
  19. 39259

    Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Act... by Katja Linher-Melville (182337)

    Published 2016
    “…We propose that careful classification of a patient’s breast cancer subtype is central to effectively targeting STAT3/5 as a therapeutic means of treating breast cancer, particularly given that xCT is emerging as an important biomarker of aggressive cancers.…”
  20. 39260